Advances in Antithrombotic Therapy: Update on NOACs

Traditional anticoagulant drugs, including unfractionated heparin and warfarin, have several limitations. Until now, vitamin K antagonists, such as warfarin, are the only clinically available oral anticoagulants. Due to the variable effect of warfarin among patients and over time in the same individual, repeated monitoring and careful adjustmenets of warfarin dosages is necessary. In spite of these adjustments oral anticoagulation is associated with an increased risk of bleeding complications. This course discusses advances in antithrombotic therapies and non-vitamin K antagonist oral anticoagulants (NOACs).

Target Audience

Cardiologists, Interventional Cardiologists, Interventional Radiologists, General Internists, Primary Care Physicians, Intensivist, Pulmonologists, General Surgeons, Orthopedic Surgeons, Urologists, Gynecologists, Anesthesiologists, Emergency Medicine Physicians, Hospitalists, Allied Health Professionals and Physicians Assistants.

Learning Objectives

  • Analyze clinical studies of non-vitamin K antagonist oral anticoagulants (NOACs) and their impact on prevention and treatment of venous thromboembolism (VTE).
  • Implement strategies for the proper management and reversal of NOACs. 
Additional information
Bibliography: 

Sinnaeve, P. R., & Van de Werf, F. J. (2004). Will oral antithrombin agents replace warfarin? Heart, 90(8), 827–828. http://doi.org/10.1136/hrt.2003.030379

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Nurse Practitioners
  • 1.00 General certificate of attendance
Course opens: 
07/15/2014
Course expires: 
03/01/2017

Alexander G. G. Turpie, M.D., FRCP, FACP, FACC, FRCPC
Professor of Medicine
McMaster University 
Hamilton, Ontario, Canada

Alexander G. G. Turpie, M.D., FRCP, FACP, FACC, FRCPC, has indicated that he is a consultant for Bayer Pharma, Portola, Janssen, BI and BMS/Pfizer and is on the speakers’ bureau for Janssen, BI and BMS/Pfizer. His presentation will not include discussion of off-label (unapproved) usage. 

Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose. 

Disclosure Policy and Disclaimer

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Nurse Practitioners
  • 1.00 General certificate of attendance

Accreditation Period

Course opens: 
07/15/2014
Course expires: 
03/01/2017
Please login or register to take this course.

Required Hardware/software

This site is best viewed on the two most recent stable releases of the following browsers for all public pages:

PCs Running Windows

  • Google Chrome (Preferred): Download free web browser for PC, Mac, phone and tablet
  • Internet Explorer (IE 11 and above recommended): You will be prompted to download videos before you are able to view. Click “download” to view video.  After a momentary pause, the recording will play. 
  • Mozilla Firefox: You may be prompted under the “This Connection is Untrusted” screen to add “cmeonline.baptisthealth.net” and “cdn.baptisthealth.net” under “add exceptions”.

Apple Computers Running OSX

  • Google Chrome (Preferred): Download free web browser for PC, Mac, phone and tablet
  • Safari
  • Mozilla Firefox: You may be prompted under the “This Connection is Untrusted” screen to add “cmeonline.baptisthealth.net” and “cdn.baptisthealth.net” under “add exceptions”.

This site uses a responsive design, which allows the page layout of elements to change depending on the screen resolution. Certain functionality may change based on the screen resolution of smaller screens, such as the number of columns in a table.

Technical Support: If you are experiencing technical difficulties or have received an error message, please send an email to CME@BaptistHealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.